Engineers Gate Manager’s KalVista Pharmaceuticals KALV Stock Holding History

Engineers Gate Manager’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$225K	Buy	+11,180	New	+$180K	﹤0.01%	1857
2025 Q3	–	Sell	-26,257	Closed	-$297K	–	2355
2025 Q2	$297K	Buy	26,257 +415	+2%	+$5.07K	﹤0.01%	1735
2025 Q1	$298K	Buy	+25,842	New	+$264K	0.01%	1708
2022 Q3	–	Sell	-16,721	Closed	-$165K	–	1853
2022 Q2	$165K	Buy	+16,721	New	+$184K	0.01%	1660

Other funds holding KALV

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Engineers Gate Manager's KALV Position: Q1 2026 in Review

Engineers Gate Manager opened a new position in KalVista Pharmaceuticals (KALV) in Q1 2026: 11,180 shares worth $225K. The stake represents ﹤0.01% of the portfolio and ranks #1857 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in KALV as recently as Q2 2025.

Engineers Gate Manager first reported a position in KALV in Q2 2022 and has held it in 4 quarters since. The position peaked at $298K in Q1 2025. 183 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

Engineers Gate Manager held 11,180 shares of KalVista Pharmaceuticals worth $225K as of Q1 2026.
KalVista Pharmaceuticals was a new Engineers Gate Manager position in Q1 2026.
KalVista Pharmaceuticals made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1857 holding.
Engineers Gate Manager first reported a position in KalVista Pharmaceuticals in Q2 2022 and has held it in 4 quarters since.
Engineers Gate Manager's KalVista Pharmaceuticals position peaked at $298K in Q1 2025.
183 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.